Impact BioMedical, Inc. (IBO)
3.268
+0.21
(+6.78%)
USD |
NYAM |
Oct 20, 16:00
3.12
-0.15
(-4.51%)
After-Hours: 07:25
Impact BioMedical Gross Profit (TTM) : -1.532M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.532M |
| March 31, 2026 | -1.542M |
| December 31, 2025 | -1.547M |
| September 30, 2025 | -1.125M |
| June 30, 2025 | -1.135M |
| March 31, 2025 | -1.122M |
| December 31, 2024 | -1.119M |
| September 30, 2024 | -1.12M |
| June 30, 2024 | -1.119M |
| March 31, 2024 | -1.12M |
| December 31, 2023 | -1.12M |
| September 30, 2023 | -1.118M |
| June 30, 2023 | -1.117M |
| March 31, 2023 | -1.065M |
| Date | Value |
|---|---|
| December 31, 2022 | -1.063M |
| September 30, 2022 | -1.063M |
| June 30, 2022 | -1.062M |
| March 31, 2022 | -1.113M |
| December 31, 2021 | -1.113M |
| September 30, 2021 | -0.835M |
| June 30, 2021 | -0.5565M |
| March 31, 2021 | -0.2782M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| September 30, 2019 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| LENZ Therapeutics, Inc. | 19.36M |
| Enveric Biosciences, Inc. | -0.1539M |
| ANI Pharmaceuticals, Inc. | 505.18M |
| Corcept Therapeutics, Inc. | 816.73M |
| Veru, Inc. | -0.113M |